DescriptionHelius Medical Technologies Inc is a medical technology company. It is focused on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company has developed its first, known as the portable neuromodulation stimulator or PoNS, device, is designed to enhance the brain's ability to compensate for this damage.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 0.50 +4.00% increase |
| 0.65 -20.00% decrease |
| -0.03 (-5.45%) decrease |
|3-Month|| 0.50 +4.00% increase |
| 0.89 -41.57% decrease |
| -0.08 (-13.33%) decrease |
|52-Week|| 0.35 +48.57% increase |
| 2.44 -78.69% decrease |
| -1.78 (-77.39%) decrease |